1. Home
  2. ORCL vs MRK Comparison

ORCL vs MRK Comparison

Compare ORCL & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oracle Corporation

ORCL

Oracle Corporation

HOLD

Current Price

$157.65

Market Cap

339.1B

Sector

Technology

ML Signal

HOLD

Logo Merck & Company Inc. (new)

MRK

Merck & Company Inc. (new)

HOLD

Current Price

$150.50

Market Cap

317.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORCL
MRK
Founded
1977
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
339.1B
317.8B
IPO Year
2005
1995

Fundamental Metrics

Financial Performance
Metric
ORCL
MRK
Price
$157.65
$150.50
Analyst Decision
Buy
Buy
Analyst Count
36
17
Target Price
$260.11
$125.59
AVG Volume (30 Days)
18.0M
7.7M
Earning Date
06-10-2026
04-30-2026
Dividend Yield
1.22%
3.06%
EPS Growth
34.33
8.01
EPS
5.83
N/A
Revenue
$67,357,000,000.00
$65,011,000,000.00
Revenue This Year
$19.50
$3.61
Revenue Next Year
$31.91
$5.41
P/E Ratio
$26.67
N/A
Revenue Growth
17.35
1.31
52 Week Low
$114.50
$77.58
52 Week High
$345.72
$157.00

Technical Indicators

Market Signals
Indicator
ORCL
MRK
Relative Strength Index (RSI) 58.39 65.79
Support Level $136.56 $110.22
Resistance Level $164.31 $157.00
Average True Range (ATR) 5.58 3.88
MACD 0.47 0.00
Stochastic Oscillator 93.28 78.26

Price Performance

Historical Comparison
ORCL
MRK

About ORCL Oracle Corporation

Oracle provides enterprise applications and infrastructure offerings through a variety of flexible IT deployment models, including on-premises, cloud-based, and hybrid. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system, which is commonly used by the world's largest companies for high-volume online transaction processing workloads. Besides databases, Oracle also sells enterprise resource planning platforms and cloud infrastructure that play an increasingly important role in large language model training and inferencing.

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Share on Social Networks: